Trends in Obesity Prevalence Among Patients Enrolled in Clinical Trials for Obesity-Related Cancers, 1986 to 2016

por Vaidya, Riha, Till, Cathee, Greenlee, Heather, Hershman, Dawn L., Unger, Joseph M.
Publicado 2022

Predictors of Pain Reduction in Trials of Interventions for Aromatase Inhibitor–Associated Musculoskeletal Symptoms

por Henry, N Lynn, Unger, Joseph M, Till, Cathee, Crew, Katherine D, Fisch, Michael J, Hershman, Dawn L
Publicado 2021

“When Offered to Participate”: A Systematic Review and Meta-Analysis of Patient Agreement to Participate in Cancer Clinical Trials

por Unger, Joseph M, Hershman, Dawn L, Till, Cathee, Minasian, Lori M, Osarogiagbon, Raymond U, Fleury, Mark E, Vaidya, Riha
Publicado 2020

Associations Between Polymorphisms in Genes Related to Oxidative Stress and DNA Repair, Interactions With Serum Antioxidants, and Prostate Cancer Risk: Results From the Prostate Ca...

por Gong, Zhihong, Platek, Mary E., Till, Cathee, Goodman, Phyllis J., Tangen, Catherine M., Platz, Elizabeth A., Neuhouser, Marian L., Thompson, Ian M., Santella, Regina M., Ambrosone, Christine B.
Publicado 2022

Finasteride Concentrations and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial

por Chau, Cindy H., Price, Douglas K., Till, Cathee, Goodman, Phyllis J., Chen, Xiaohong, Leach, Robin J., Johnson-Pais, Teresa L., Hsing, Ann W., Hoque, Ashraful, Tangen, Catherine M., Chu, Lisa, Parnes, Howard L., Schenk, Jeannette M., Reichardt, Juergen K. V., Thompson, Ian M., Figg, William D.
Publicado 2015

Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case–control study

por Yao, Song, Till, Cathee, Kristal, Alan R., Goodman, Phyllis J., Hsing, Ann W., Tangen, Catherine M., Platz, Elizabeth A., Stanczyk, Frank Z., Reichardt, Juergen K. V., Tang, Li, Neuhouser, Marian L., Santella, Regina M., Figg, William D., Price, Douglas K., Parnes, Howard L., Lippman, Scott M., Thompson, Ian M., Ambrosone, Christine B., Hoque, Ashraful
Publicado 2011

Genetically adjusted PSA levels for prostate cancer screening

por Kachuri, Linda, Hoffmann, Thomas J., Jiang, Yu, Berndt, Sonja I., Shelley, John P., Schaffer, Kerry R., Machiela, Mitchell J., Freedman, Neal D., Huang, Wen-Yi, Li, Shengchao A., Easterlin, Ryder, Goodman, Phyllis J., Till, Cathee, Thompson, Ian, Lilja, Hans, Van Den Eeden, Stephen K., Chanock, Stephen J., Haiman, Christopher A., Conti, David V., Klein, Robert J., Mosley, Jonathan D., Graff, Rebecca E., Witte, John S.
Publicado 2023